Influence of Telemedicine on the Number of Visits and HbA1c Determinations in Latin American Children with Type 1 Diabetes

Vista sencilla de ítem
dc.contributor.authorHirschler, Valeria
dc.contributor.authorMolinari, Claudia
dc.contributor.authorFigueroa Sobrero, Angela
dc.contributor.authorPelicand, Julie
dc.contributor.authorPinto Ibárcena, Paula
dc.contributor.authorDel Aguila Villar, Carlos M.
dc.contributor.authorScaiola, Edit
dc.contributor.authorBocco, Patricia
dc.contributor.authorGonzalez, Diana S.
dc.contributor.authorMac, Ailin
dc.contributor.authorRamirez Trillo, Carolina
dc.contributor.authorMora Brito, Edgar
dc.contributor.authorAcosta, Johanna
dc.contributor.authorLapertosa, Silvia
dc.contributor.authorGonzalez, Claudio D.
dc.date.accessioned2022-11-30T02:46:46Z
dc.date.available2022-11-30T02:46:46Z
dc.date.issued2021
dc.description.abstractObjective: To measure the changes in the number of medical visits and the number of HbA1c determinations according to telemedicine access in children with type 1 diabetes (T1DM) during the pandemic 2020 compared with 2019 and 2018. Methods: This is a multinational study of children with T1DM from four Latin American countries. The number of medical visits, the number of HbA1c determinations, and access to telemedicine during 2020 were extracted from their records. Results: 227 children (59% females) aged 12.7± 3.2 years with a duration of 5.4 ± 2.7 years of T1DM in 2018 were evaluated. There was a higher prevalence of children with telemedicine access in the pandemic 2020 vs. those without (145(63.9%) vs. 82 (36.1%); p<0.01) There was a higher number of medical visits during 2020 in children with telemedicine access vs. those without (6.9 vs. 2.6; p<0.01). Children with telemedicine access had a higher number of visits in 2020 vs. 2018 (6.87 vs. 5.04, p<0.01), but similar to 2019. Children without access had a lower number of visits in 2020 vs. 2019 (2.6 vs. 5.5; p<0.01) and vs. 2018 (2.6 vs. 5.1; p<0.01). In 2020, the number of HbA1c determinations in children with telemedicine access was higher vs. those without (1.8 vs. 0.9; p<0.01). Children with telemedicine access had a lower number of Hb A1c determinations in 2020 vs. 2019 (1.8 vs. 2.4; p<0.01), but similar to 2018. Furthermore, children without access had a lower number of Hb A1c determinations in 2020 vs. 2019 (0.9 vs. 1.9; p<0.01) and vs. 2018 (0.9 vs. 2.0; p<0.01). Conclusions: We found that children with T1DM with telemedicine access had a significantly higher number of medical visits and HbA1c determinations during lockdown than those without access in different Latin American centers.en_ES
dc.facultadFacultad de Medicinaen_ES
dc.file.namePelicand_Infl2021.pdf
dc.identifier.citationHirschler V, Molinari C, Figueroa Sobrero A, et al. Influence of Telemedicine on the Number of Visits and HbA1c Determinations in Latin American Children with Type 1 Diabetes. Diabetes Technol Ther. 2021;23(11):731-736. doi:10.1089/dia.2021.0189en_ES
dc.identifier.doi10.1089/dia.2021.0189
dc.identifier.urihttp://repositoriobibliotecas.uv.cl/handle/uvscl/7489
dc.languageen
dc.publisherMary Ann Liebert, Inc
dc.sourceDiabetes technology & therapeutics
dc.titleInfluence of Telemedicine on the Number of Visits and HbA1c Determinations in Latin American Children with Type 1 Diabetes
dc.typeArticulo
uv.departamentoEscuela de Medicina
uv.notageneralNo disponible para descarga

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Pelicand_Infl2021_noaccesible_.pdf
Tamaño:
601.47 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar

Colecciones

Artículos investigadores UV